fadrozole has been researched along with aldosterone in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (7.69) | 18.7374 |
1990's | 5 (19.23) | 18.2507 |
2000's | 4 (15.38) | 29.6817 |
2010's | 13 (50.00) | 24.3611 |
2020's | 2 (7.69) | 2.80 |
Authors | Studies |
---|---|
Aupetit, B; Bhatnagar, AS; Ezzet, F; Girard, F; Menard, J; Mueller, P; Trunet, PF; Zognbi, F | 1 |
Demers, LM; Garber, JE; Hanagan, J; Harvey, H; Henderson, IC; Lipton, A; Lynch, J; Mulagha, M; Navari, RM; Santen, RJ | 1 |
Coombes, RC; Davenport, J; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC | 1 |
Demers, LM; Harvey, HA; Lipton, A; Melby, JC; Santen, RJ; Wilson, TE | 1 |
Bhatnagar, AS; Borer, C; Häusler, A; Monnet, G | 1 |
Blijd, JJ; Bruining, HA; De Jong, FH; Hackeng, WH; Lamberts, SW; Marzouk, H; Uitterlinden, P; Zuiderwijk, J | 1 |
Demers, LM; Hanagan, J; Harvey, HA; Lipton, A; Mulagha, M; Santen, RJ | 1 |
Kimura, M; Nomura, Y; Ohashi, Y; Takashima, S; Toge, T; Tominaga, T | 1 |
Angotti, M; Hartmann, RW; Müller-Vieira, U | 1 |
Bissery, A; Gonzalez, MF; Guyene, TT; Ménard, J | 1 |
Beugels, IP; Cohuet, GM; de Gooyer, ME; Emmen, JM; Hermans, JJ; Hilbers, PA; Minnaard-Huiban, M; Ottenheijm, HC; Pieterse, K; Plate, R; Roumen, L; Ruijters, E; Smits, JF; van Essen, H | 1 |
Beil, M; Fu, F; Hu, CW; Jeng, AY; Liang, G; Rigel, DF | 1 |
Ahmad, M; Ahmadi, S; Huang, BS; Leenen, FH; White, RA | 1 |
Coleman, R; Gamliel-Lazarovich, A; Gantman, A; Jeng, AY; Kaplan, M; Keidar, S | 1 |
Briones, AM; Callera, GE; He, Y; Montezano, AC; Nguyen Dinh Cat, A; Touyz, RM; Yogi, A | 1 |
Arrowsmith, CH; Edwards, AM; Gilep, AA; Park, HW; Shen, L; Strushkevich, N; Usanov, SA | 1 |
Kumagai, H; Nishida, Y; Oda, T; Onimaru, H; Oshima, N; Takechi, H; Uchida, T; Watanabe, A; Yamamoto, K | 1 |
Brown, NJ | 1 |
Ahmad, M; Huang, BS; Leenen, FH; White, RA | 1 |
Hartmann, RW; Hu, Q; Yin, L | 1 |
Ahmad, M; Chen, A; Huang, BS; Leenen, FH; Wang, HW; White, RA | 1 |
Bornstein, SR; Brown, NF; Brunssen, C; Deussen, A; Eisenhofer, G; Engelmann, F; Hofmann, A; Huber, J; Jannasch, A; Martin, M; Mittag, J; Morawietz, H; Peitzsch, M; Streicher, R; Weldon, SM | 1 |
Du, N; Du, Y; Gu, H; Kowala, MC; Ma, Z; Shatara, A; Wang, J; Yi, X; Zhu, T | 1 |
Bornstein, SR; Brown, NF; Brunssen, C; Eisenhofer, G; Frenzel, A; Hofmann, A; Morawietz, H; Peitzsch, M; Weldon, SM; Willenberg, HS; Ziegler, CG | 1 |
Korpela, R; Launonen, H; Linden, J; Luiskari, L; Salmenkari, H; Siltari, A; Vapaatalo, H | 1 |
Groessl, M; Hafele, E; Kollar, J; Pignatti, E; Schumacher, C; Schuster, D; Steele, RE; Vogt, B | 1 |
1 review(s) available for fadrozole and aldosterone
Article | Year |
---|---|
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.
Topics: Aldosterone; Animals; Aromatase Inhibitors; Cardiovascular System; Cytochrome P-450 CYP11B2; Endothelial Cells; Fadrozole; Fibrosis; Humans; Imidazoles; Inflammation; Kidney; Macrophages; Mineralocorticoid Receptor Antagonists; Myocardium; Myocytes, Cardiac; Pyridines; Reactive Oxygen Species; Receptors, Mineralocorticoid; Sodium, Dietary | 2013 |
3 trial(s) available for fadrozole and aldosterone
Article | Year |
---|---|
The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects.
Topics: Adult; Aldosterone; Cosyntropin; Desoxycorticosterone; Double-Blind Method; Estradiol; Estrogen Antagonists; Estrone; Fadrozole; Furosemide; Humans; Hydrocortisone; Imidazoles; Nitriles; Posture; Reference Values; Renin | 1992 |
The effects of long term fadrozole hydrochloride treatment in patients with advanced stage breast cancer.
Topics: Adrenocorticotropic Hormone; Aldosterone; Breast Neoplasms; Estradiol; Estrone; Fadrozole; Female; Humans; Hydrocortisone; Neoplasm Staging | 1993 |
[A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen].
Topics: Aged; Aldosterone; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Fadrozole; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Postmenopause; Tamoxifen | 2000 |
22 other study(ies) available for fadrozole and aldosterone
Article | Year |
---|---|
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrone; Fadrozole; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Imidazoles; Kinetics; Menopause; Nitriles | 1991 |
Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A.
Topics: Aldosterone; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Evaluation; Electrolytes; Estradiol; Fadrozole; Female; Humans; Imidazoles; Menopause; Nitriles; Receptors, Estrogen | 1990 |
The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis.
Topics: 18-Hydroxycorticosterone; Adrenal Cortex; Adrenocorticotropic Hormone; Aged; Aldosterone; Aromatase Inhibitors; Binding Sites; Breast Neoplasms; Chemical Phenomena; Chemistry; Cytochrome P-450 CYP11B2; Cytochrome P-450 Enzyme Inhibitors; Electrolytes; Fadrozole; Female; Humans; Hydrocortisone; Imidazoles; In Vitro Techniques; Mineralocorticoids; Mixed Function Oxygenases; Nitriles | 1990 |
Evidence that corticosterone is not an obligatory intermediate in aldosterone biosynthesis in the rat adrenal.
Topics: Adrenal Glands; Aldosterone; Aminoglutethimide; Animals; Aromatase Inhibitors; Corticosterone; Cosyntropin; Delayed-Action Preparations; Desoxycorticosterone; Fadrozole; Imidazoles; In Vitro Techniques; Male; Nitriles; Rats; Rats, Inbred Strains | 1989 |
The new aromatase inhibitor CGS-16949A suppresses aldosterone and cortisol production by human adrenal cells in vitro.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Aldosterone; Aromatase Inhibitors; Cells, Cultured; Fadrozole; Female; Humans; Hydrocortisone; Imidazoles; Kinetics; Male; Nitriles | 1989 |
The adrenocortical tumor cell line NCI-H295R as an in vitro screening system for the evaluation of CYP11B2 (aldosterone synthase) and CYP11B1 (steroid-11beta-hydroxylase) inhibitors.
Topics: Adrenal Cortex; Aldosterone; Aromatase Inhibitors; Cell Line, Tumor; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fadrozole; Humans; Steroid 11-beta-Hydroxylase; Steroids | 2005 |
Investigation of aldosterone-synthase inhibition in rats.
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Cytochrome P-450 CYP11B2; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Fadrozole; Furosemide; Hypokalemia; Male; Mineralocorticoid Receptor Antagonists; Potassium; Potassium, Dietary; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Sodium; Sodium, Dietary; Urea | 2006 |
Fadrozole reverses cardiac fibrosis in spontaneously hypertensive heart failure rats: discordant enantioselectivity versus reduction of plasma aldosterone.
Topics: Aldosterone; Animals; Canrenoic Acid; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Drug Evaluation, Preclinical; Fadrozole; Fibrosis; Gene Expression Regulation; Heart; Heart Failure; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Inbred SHR; Stereoisomerism; Structure-Activity Relationship; Treatment Outcome | 2008 |
Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11beta-hydroxylase inhibitor metyrapone.
Topics: Adrenal Glands; Aldosterone; Animals; Blood Pressure; Blood Proteins; Chromatography, Liquid; Corticosterone; Cytochrome P-450 CYP11B2; Disease Models, Animal; Enzyme Inhibitors; Fadrozole; Hyperaldosteronism; Imidazoles; In Vitro Techniques; Male; Mass Spectrometry; Metyrapone; Protein Binding; Pyridines; Rats; Rats, Sprague-Dawley; Steroid 11-beta-Hydroxylase | 2010 |
Central neuronal activation and pressor responses induced by circulating ANG II: role of the brain aldosterone-"ouabain" pathway.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brain; Cardenolides; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Fadrozole; Heart Rate; Hypothalamus; Imidazoles; Immunoglobulin Fab Fragments; Immunohistochemistry; Infusion Pumps, Implantable; Infusions, Parenteral; Infusions, Subcutaneous; Male; Mineralocorticoid Receptor Antagonists; Neural Pathways; Neurons; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Rats, Wistar; Renin-Angiotensin System; Saponins; Spironolactone; Subfornical Organ; Telemetry; Time Factors | 2010 |
FAD286, an aldosterone synthase inhibitor, reduced atherosclerosis and inflammation in apolipoprotein E-deficient mice.
Topics: Aldosterone; Animals; Apolipoproteins E; Atherosclerosis; Cell Line; Cytochrome P-450 CYP11B2; Diet, Sodium-Restricted; Enzyme Inhibitors; Fadrozole; Imidazoles; Inflammation; Macrophages; Male; Mice; Mice, Knockout; Pyridines | 2010 |
Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.
Topics: 3T3-L1 Cells; Adipocytes; Aldosterone; Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Corticosterone; Culture Media, Conditioned; Eplerenone; Fadrozole; Fibronectins; Hormone Antagonists; Mice; Mice, Inbred C57BL; Mifepristone; Mineralocorticoid Receptor Antagonists; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Receptor, Angiotensin, Type 1; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 2011 |
Structural insights into aldosterone synthase substrate specificity and targeted inhibition.
Topics: Aldosterone; Blood Pressure; Catalysis; Crystallography, X-Ray; Cytochrome P-450 CYP11B2; Desoxycorticosterone; Fadrozole; Humans; Hypertension; Models, Molecular; Protein Structure, Tertiary; Renin-Angiotensin System; Steroid 11-beta-Hydroxylase; Substrate Specificity; Water-Electrolyte Balance | 2013 |
Aldosterone is synthesized in and activates bulbospinal neurons through mineralocorticoid receptors and ENaCs in the RVLM.
Topics: Aldosterone; Amiloride; Animals; Aromatase Inhibitors; Calcium; Diuretics; Epithelial Sodium Channels; Eplerenone; Excitatory Postsynaptic Potentials; Fadrozole; Magnesium; Medulla Oblongata; Membrane Potentials; Neurons; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, Mineralocorticoid; Spinal Cord; Spironolactone; Tissue Fixation | 2013 |
Role of brain corticosterone and aldosterone in central angiotensin II-induced hypertension.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Brain; Corticosterone; Cytochrome P-450 CYP11B2; Dose-Response Relationship, Drug; Eplerenone; Fadrozole; Heart Rate; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Spironolactone | 2013 |
Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases.
Topics: Aldosterone; Animals; Benzimidazoles; Cardiovascular Diseases; Cytochrome P-450 CYP11B2; Fadrozole; Humans; Indans; Indoles; Kidney Diseases; Mineralocorticoids; Naphthalenes; Quinolines; Receptors, Mineralocorticoid | 2014 |
Role of brain aldosterone and mineralocorticoid receptors in aldosterone-salt hypertension in rats.
Topics: Aldosterone; Animals; Arterial Pressure; Corticosterone; Cytochrome P-450 CYP11B2; Drinking Behavior; Eplerenone; Fadrozole; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Neurons; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Receptors, Mineralocorticoid; RNA, Messenger; Sodium Chloride; Spironolactone; Subfornical Organ; Supraoptic Nucleus | 2016 |
Aldosterone Synthase Inhibition Improves Glucose Tolerance in Zucker Diabetic Fatty (ZDF) Rats.
Topics: Adrenal Glands; Aldosterone; Animals; Blood Glucose; Body Weight; Cytochrome P-450 CYP11B2; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Evaluation, Preclinical; Eating; Eplerenone; Fadrozole; Glucose Tolerance Test; Glycated Hemoglobin; Insulin; Insulin Resistance; Insulin Secretion; Liver; Male; Mineralocorticoid Receptor Antagonists; Organ Size; Potassium; Random Allocation; Rats, Zucker; Sodium; Spironolactone; Triglycerides | 2016 |
Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice.
Topics: Aldosterone; Animals; Biomarkers; Blood Pressure; Cytochrome P-450 CYP11B2; Electrolytes; Fadrozole; Gene Expression; Genotype; Hematocrit; Humans; Hypertension; Kidney; Mice; Mice, Transgenic; Phenotype; Renin; Sodium Chloride, Dietary; Steroid 11-beta-Hydroxylase | 2017 |
Impact of Aldosterone Synthase Inhibitor FAD286 on Steroid Hormone Profile in Human Adrenocortical Cells.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Cell Line; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Fadrozole; Gene Expression Regulation, Enzymologic; Glucocorticoids; Hormones; Humans; Receptor, Angiotensin, Type 1; RNA, Messenger; Steroids; Tetrazoles | 2017 |
Adverse effects of an aldosterone synthase (CYP11B2) inhibitor, fadrozole (FAD286), on inflamed rat colon.
Topics: Aldosterone; Animals; Colon; Cytochrome P-450 CYP11B2; Fadrozole; Iatrogenic Disease; Inflammation; Mice; Rats; Rats, Sprague-Dawley | 2023 |
Structural and clinical characterization of CYP11B2 inhibition by dexfadrostat phosphate.
Topics: Aldosterone; Corticosterone; Cytochrome P-450 CYP11B2; Fadrozole; Humans; Phosphates; Steroid 11-beta-Hydroxylase | 2023 |